Recent developments include Gentherm's completion of the Modine Transaction, updates on third quarter 2026 financial results, and ongoing business awards and strategic initiatives.

• Gentherm completed the Reverse Morris Trust transaction with Modine Manufacturing Co. on October 1, 2026, acquiring Modine's Performance Technologies business, which became a wholly owned subsidiary [N1][N3].
• Following the Modine Transaction, Modine shareholders own approximately 43.62% of Gentherm's outstanding common stock, with prior Gentherm shareholders owning approximately 56.38% [N3].
• Gentherm declared and paid a special cash dividend of $63.5 million ($2.07 per share) to shareholders in connection with the Modine Transaction [N3].
• SpinCo, the Modine subsidiary, borrowed $250 million under a delayed-draw term loan facility to fund the SpinCo Cash Distribution and other closing costs; this debt is now indebtedness of a Gentherm subsidiary [N3].
• Gentherm reported product revenues of $405.1 million for Q3 2026, an increase from $386.9 million in the prior year period, with gross margin of $94.3 million [N2][N3].
• Operating expenses increased due to Modine Transaction-related costs, with selling, general and administrative expenses rising to $51.6 million from $42.9 million year-over-year [N2][N3].
• The company secured automotive new business awards totaling $555 million in Q3 2026, indicating ongoing customer engagement [N3].
• Gentherm's Board authorized a new 2026 Stock Repurchase Program to repurchase up to $400 million of common stock over three years, replacing the prior program [N3].
• Gentherm's Q3 2026 earnings per share were -$0.08 basic and diluted [N2].
• The company continues to monitor and manage risks related to tariffs, geopolitical conflicts, inflation, and supply chain disruptions [N1][N4].

Gentherm's integration of Modine's Performance Technologies business expands its product offerings beyond automotive into broader thermal management markets, potentially increasing revenue diversification. The acquisition of Innovative Medical Equipment, LLC adds innovative medical thermal therapy solutions, enhancing the medical segment. The company's global manufacturing footprint and proximity to key customers support operational flexibility and cost efficiency. Securing substantial new business awards indicates ongoing customer confidence and potential revenue streams. The company's focus on innovation and adaptation to industry trends positions it to capitalize on increasing demand for comfort, health, and wellness features in vehicles and medical devices.

Gentherm faces risks from global trade uncertainties, including tariffs and geopolitical conflicts that could disrupt supply chains and increase costs. Inflationary pressures and rising input costs have adversely impacted operating expenses, with limited ability to fully pass these costs to customers. The automotive industry's cyclical nature and fluctuations in light vehicle production volumes can materially affect Gentherm's revenues and profitability. Foreign currency exchange rate volatility introduces additional financial risk. Integration challenges and costs related to recent acquisitions, including the Modine Transaction, may affect operational efficiency and financial results. These factors could constrain Gentherm's financial performance and market position.

Gentherm's moat is supported by its leadership in thermal management technologies, diversified product portfolio across automotive and medical segments, and a global manufacturing footprint aligned with key customer locations. Its ability to innovate and collaborate with vehicle OEMs and seat manufacturers globally enables unique product configurations that adapt to evolving industry trends. The company's diversified OEM customer base and geographic revenue distribution, combined with a flexible cost structure, provide resilience against industry downturns. Additionally, strategic acquisitions such as the Modine Performance Technologies business and Innovative Medical Equipment, LLC enhance its technological capabilities and market reach. These factors collectively contribute to Gentherm's competitive positioning and barriers to entry for competitors.

• Global Trade and Tariffs: Ongoing tariffs and reciprocal trade restrictions create uncertainty and potential cost increases. Gentherm mitigates impacts through regional manufacturing and cost pass-through but remains exposed to changes in trade policies [S1][S2].
• Geopolitical Conflicts: Conflicts such as those in Russia-Ukraine and the Middle East disrupt ocean freight shipping and could adversely affect suppliers and OEM customers, impacting production and financial results [S1][S2].
• Inflationary Pressures: Rising costs of materials, labor, equipment, freight, and logistics have increased operating expenses. The company has limited ability to fully mitigate or pass these costs to customers [S1][S2].
• Foreign Currency Risk: Translation and remeasurement of international operations expose Gentherm to currency fluctuations, potentially causing volatility in financial results [S1][S2].
• Automotive Industry Cyclicality: Dependence on light vehicle production volumes and consumer demand exposes Gentherm to industry downturns, which can materially affect revenues and profitability [S1][S2].
• Acquisition Integration: Costs and operational challenges related to the Modine Transaction and other acquisitions may affect efficiency and financial performance [S2].

• Gentherm Inc is a global leader in innovative thermal management and precision flow management technologies, serving automotive and medical markets [S1][S2].
• Automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, Valve Systems, and Climate and Comfort Electronics [S1][S2].
• Medical products include patient temperature management systems used in hospitals worldwide [S1][S2].
• The company operates globally with manufacturing, assembly, distribution, warehousing, engineering, and testing facilities in over 30 locations across 13 countries, including North America, Europe, China, Japan, South Korea, and others [S1].
• Gentherm's automotive sales depend on light vehicle production volumes by OEMs in key markets and product content per vehicle, influenced by macroeconomic factors and consumer preferences [S1][S2].
• The company completed a Reverse Morris Trust transaction with Modine Manufacturing Co. on October 1, 2026, acquiring Modine's Performance Technologies business, which became a wholly owned subsidiary [S2].
• Following the Modine Transaction, Modine shareholders own approximately 43.62% of Gentherm's outstanding common stock, and prior Gentherm shareholders own approximately 56.38% [S2].
• Gentherm declared and paid a special cash dividend of $63.5 million ($2.07 per share) to shareholders in connection with the Modine Transaction [S2].
• SpinCo, the Modine subsidiary, borrowed $250 million under a delayed-draw term loan facility to fund the SpinCo Cash Distribution and other closing costs; this debt is now indebtedness of a Gentherm subsidiary [S2].
• Gentherm acquired Innovative Medical Equipment, LLC on July 1, 2026, adding the ThermaZone® thermal therapy device to its Medical segment [S2].
• The company has a global manufacturing footprint enabling regional production aligned with customer locations and the ability to shift production between regions [S1][S2].
• Gentherm faces risks from tariffs and global trade environment changes, including additional tariffs imposed since March 2025 and reciprocal tariffs by other countries; the company mitigates impacts through regional manufacturing and passing costs to customers where possible [S1][S2].
• Global automotive light vehicle production volumes in Gentherm's key markets decreased approximately 3.5% in the nine months ended September 30, 2026, compared to the prior year [S2].
• Gentherm secured automotive new business awards totaling $555 million in the third quarter of 2026, representing projected lifetime revenue from new awards [S2].
• The company terminated its 2024 Stock Repurchase Program and authorized a new 2026 Stock Repurchase Program to repurchase up to $400 million of common stock over three years; $340 million remained authorized as of the report date [S2].
• Financial snapshot as of September 30, 2026: cash and equivalents of $252.1 million, current assets of $927.5 million, current liabilities of $451.9 million, current ratio of 2.05, and cash ratio of 0.58 [S2].
• Earnings per share basic and diluted were both -$0.08 for the quarter ended September 30, 2026 [S2].
• Product revenues for the three months ended September 30, 2026, were $405.1 million, up from $386.9 million in the prior year period; gross margin was $94.3 million [S2].
• Operating expenses increased, including selling, general and administrative expenses rising to $51.6 million from $42.9 million year-over-year, partly due to Modine Transaction costs [S2].
• Gentherm's Board of Directors oversees strategy and risk management, including cybersecurity risks, with dedicated committees and experienced leadership [S1].
• The company operates manufacturing and distribution facilities close to key customers and in low-cost regions, with most North American and Asian sites leased and most European sites owned [S1].
• Gentherm's business model emphasizes innovation and cooperation with vehicle OEMs and seat manufacturers globally to adapt to industry trends [S1][S2].
• The company faces risks from geopolitical conflicts affecting ocean freight shipping and potential trade restrictions that could impact suppliers and OEM customers [S1][S2].
• Gentherm's diversified OEM customer base and geographic revenue base, along with a flexible cost structure, position it to withstand industry downturns and benefit from upturns [S1][S2].
• The company continues to face inflationary pressures and rising costs of materials, labor, equipment, freight, and logistics, which have impacted operating costs and results [S1][S2].
• Gentherm is exposed to foreign currency risk due to international operations and currency translation effects [S1][S2].
• The company incurred $6.3 million and $33.4 million of costs related to the Modine Transaction during the three and nine months ended September 30, 2026, respectively, recorded in selling, general and administrative expenses [S2].
• Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.